192 filings
Page 2 of 10
6-K
NBTX
Nanobiotix
8 Nov 23
NANOBIOTIX Announces Closing of Global Offering
7:53am
6-K
NBTX
Nanobiotix
7 Nov 23
Current report (foreign)
7:02am
424B5
NBTX
Nanobiotix
6 Nov 23
Prospectus supplement for primary offering
4:12pm
FWP
NBTX
Nanobiotix
2 Nov 23
Free writing prospectus
4:36pm
6-K
NBTX
Nanobiotix
2 Nov 23
NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M
10:56am
FWP
NBTX
Nanobiotix
2 Nov 23
Free writing prospectus
12:00am
424B5
NBTX
Nanobiotix
1 Nov 23
Prospectus supplement for primary offering
6:50pm
6-K
NBTX
Nanobiotix
1 Nov 23
NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant
6:36pm
6-K
NBTX
Nanobiotix
23 Oct 23
Strategic Collaborator-presented Phase 1 Pancreatic Cancer Data
6:00am
6-K
NBTX
Nanobiotix
11 Oct 23
Voting Rights and Shares Capital of the Company
5:24pm
6-K
NBTX
Nanobiotix
4 Oct 23
Current report (foreign)
4:43pm
6-K
NBTX
Nanobiotix
29 Sep 23
Current report (foreign)
4:15pm
6-K
NBTX
Nanobiotix
28 Sep 23
NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer
4:15pm
6-K
NBTX
Nanobiotix
26 Sep 23
Current report (foreign)
4:33pm
6-K
NBTX
Nanobiotix
26 Sep 23
NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023
4:15pm
6-K
NBTX
Nanobiotix
19 Sep 23
Current report (foreign)
4:15pm
6-K
NBTX
Nanobiotix
13 Sep 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
NBTX
Nanobiotix
5 Sep 23
NANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Leader Dr. Louis Kayitalire as Chief Medical Officer
4:15pm
6-K
NBTX
Nanobiotix
31 Aug 23
NANOBIOTIX to Present at the H.C. Wainwright 25th Annual Global Investment Conference
4:15pm
6-K
NBTX
Nanobiotix
15 Aug 23
Current report (foreign)
4:15pm